The Generic Drug Maze
| Author | : United States. Congress. Senate. Special Committee on Aging |
| Publisher | : |
| Total Pages | : 112 |
| Release | : 2006 |
| Genre | : Competition |
| ISBN | : |
The Generic Drug Maze
Download The Generic Drug Maze full books in PDF, epub, and Kindle. Read online free The Generic Drug Maze ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Cracking the Generics code
| Author | : Subba Rao Chaganti |
| Publisher | : BSP Books |
| Total Pages | : 547 |
| Release | : 2023-06-01 |
| Genre | : Business & Economics |
| ISBN | : 9390211646 |
The empowered patients, new-age technologies such as artificial intelligence (AI), machine learning (ML), big data analytics, real-world data and evidence, blockchain, electronic health records (EHRs), digital therapeutics, cloud computing, and innovative marketing frameworks like design thinking, customer journey mapping, omnichannel, closed-loop marketing, personalization and agile ways of working are transforming the way healthcare is delivered, affecting the pharmaceutical industry. Additionally, big tech companies such as Amazon, Alphabet, Apple, and Microsoft are disrupting by offering non-pharmacological solutions with innovative digital technologies to provide a seamless customer experience in the patient journey. The recent COVID-19 pandemic added rocket fuel to the digital transformation of the pharmaceutical industry, changing the entire model of care and ingraining telemedicine in the healthcare ecosystem. Digital Transformation has become inevitable and imminent. Therefore, pharma must reimagine its entire strategy and embrace digital transformation to succeed in this rapidly changing marketing environment that is becoming increasingly complex. Reimagine Pharma Marketing: Make It Future-Proof introduces all these technology frameworks. Additionally, the book presents one hundred and two case studies showing how some of the leading pharmaceutical companies are applying the new age technologies and marketing frameworks effectively. It can be your single-source guidebook unraveling the future so you can manage it!Contents: 1. Reimagine Everything — Reimagine Every Element of Pharmaceutical Marketing Mix 2. Reimagine the Technology— How Pharma Can Harness the Power of New and Emerging Technologies 3. Reimagine Stakeholder Engagement—Winning with New Rules of Engagement 4. The Future of Pharma—A Look into the Crystal Ball Epilogue You’re Gonna Need a Bigger Boat!
Managing the Documentation Maze
| Author | : Janet Gough |
| Publisher | : John Wiley & Sons |
| Total Pages | : 486 |
| Release | : 2010-03-16 |
| Genre | : Technology & Engineering |
| ISBN | : 0470597496 |
The accessible, easy-to-follow guide that demystifies documentation management When it comes to receiving documentation to confirm good science, U.S. and international regulators place high demands on the healthcare industry. As a result, companies developing and manufacturing therapeutic products must implement a strategy that allows them to properly manage their records and documents, since they must comply with rigorous standards and be available for regulatory review or inspection at a moment’s notice. Written in a user-friendly Q&A style for quick reference, Managing the Documentation Maze provides answers to 750 questions the authors encounter frequently in their roles as consultants and trainers. In simple terms, this handy guide breaks down the key components that facilitate successful document management, and shows why it needs to be a core discipline in the industry with information on: Compliance with regulations in pharmaceutical, biological, and device record keeping Electronic systems, hybrid systems, and the entire scope of documentation that companies must manage How to write and edit documents that meet regulatory compliance Making the transition to an electronic system, including how to validate and document the process Anyone responsible for managing documents in the health field will find this book to be a trusted partner in unraveling the bureaucratic web of confusion, while it initiates a plan on how to put an effective, lasting system in place—one that will stand up to any type of scrutiny.
Effects of Using Generic Drugs on Medicare's Prescription Drug Spending
| Author | : Julie Ann Somers |
| Publisher | : DIANE Publishing |
| Total Pages | : 36 |
| Release | : 2010 |
| Genre | : Health & Fitness |
| ISBN | : 1437940390 |
This is a print on demand edition of a hard to find publication. Contents:(1) Overview of the Medicare Prescription Drug Benefit Program: Design of the Medicare Prescription Drug Benefit; Distribution of Spending in Medicare Part D; The Role of Private Plans in Medicare Part D; (2) Generic Drugs in Medicare Part D: Generic Substitution; Therapeutic Substitution; Comparing Potential Savings from Generic and Therapeutic Substitution; (3) Implications of Future Developments: First-Time Generic Entry; New Brand-Name Drugs; Biologics. (4) Appendix: Description of Data Used in This Analysis. Charts and tables.
The Antitrust counterattack in intellectual property litigation handbook
| Author | : |
| Publisher | : American Bar Association |
| Total Pages | : 268 |
| Release | : |
| Genre | : Antitrust law |
| ISBN | : 9781616327736 |
Innovation for the 21st Century
| Author | : Michael A. Carrier |
| Publisher | : Oxford University Press, USA |
| Total Pages | : 421 |
| Release | : 2011-02-04 |
| Genre | : Law |
| ISBN | : 0199794286 |
'Innovation For The 21st Century' contends that intellectual property and antitrust, the two most important laws fostering innovation, are not being used most effectively to achieve this goal and offers various proposals that individually and collectively remedy this deficiency.
Medicare Part D, Prescription Drug Benefit
| Author | : United States. Congress. Senate. Special Committee on Aging |
| Publisher | : |
| Total Pages | : 40 |
| Release | : 2014 |
| Genre | : Drugs |
| ISBN | : |
FDA's Generic Drug Enforcement and Approval Process
| Author | : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations |
| Publisher | : |
| Total Pages | : 594 |
| Release | : 1992 |
| Genre | : Business & Economics |
| ISBN | : |
Goodnight Pharm: 350 Brand and Generic Drug Names with Classifications
| Author | : Tony Guerra |
| Publisher | : Lulu.com |
| Total Pages | : 254 |
| Release | : 2017-06-05 |
| Genre | : Science |
| ISBN | : 1387018116 |
I've had feedback from students that they just want me to read them drug names and mnemonics so they can put in their earbuds before they go to bed before their board exams. I've got three five year olds, I don't have time to do the heavy lifting you all do as narrators. In Memorizing Pharmacology: A Relaxed Approach, which will sell over 6,500 audiobook copies in its first year, I only had the narrator complete 200 drug names in a seven hour book. There is a list of 350 later in the book, but I thought, who in the world would want to listen to 350 drug names in a row? So I omitted it. There was an answer to that rhetorical question, health professional students studying for a board exam that are exhausted from family, work, and school want to listen to it. This print, book, however, provides a journal for you to continue to add knowledge you pick up as you complete your pharmacology class, clinicals, or even an interesting commercial or YouTube video.
Drug Wars
| Author | : Robin Feldman |
| Publisher | : Cambridge University Press |
| Total Pages | : 165 |
| Release | : 2017-06-09 |
| Genre | : Law |
| ISBN | : 131673949X |
While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.
